Copy For Citation
ARAS ATİK E., TECEN YÜCEL K., EKİNCİOĞLU A., GÜLLÜ İ.
CLINICAL AND EXPERIMENTAL HEALTH SCIENCES, vol.9, no.2, pp.178-191, 2019 (ESCI)
-
Publication Type:
Article / Article
-
Volume:
9
Issue:
2
-
Publication Date:
2019
-
Doi Number:
10.33808/clinexphealthsci.469538
-
Journal Name:
CLINICAL AND EXPERIMENTAL HEALTH SCIENCES
-
Journal Indexes:
Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
-
Page Numbers:
pp.178-191
-
Keywords:
Capecitabine, hand-foot syndrome, mechanism, case reports, PALMAR-PLANTAR ERYTHRODYSESTHESIA, METASTATIC BREAST-CANCER, SQUAMOUS-CELL CARCINOMA, SKIN REACTION, ORAL CAPECITABINE, CLINICAL PRESENTATION, COMPLETE RESPONSE, LIVER METASTASES, LUNG METASTASES, TOPICAL HENNA
-
Anadolu University Affiliated:
Yes
Abstract
Objective: Capecitabine, a prodrug of 5-fluorouracil, is currently used in the treatment of metastatic colorectal and breast cancers. The aim of this study was to review the pharmacological mechanisms, treatment strategies, and documented case reports of capecitabine-induced hand-foot syndrome (HFS).